| Drug Name: | Antazoline (91-75-8) |
|---|---|
| PubChem ID: | 2200 |
| SMILES: | C1CN=C(N1)CN(CC2=CC=CC=C2)C3=CC=CC=C3 |
| InchiKey: | REYFJDPCWQRWAA-UHFFFAOYSA-N |
| Therapeutic Category: | Anti-Allergic Agents, Histamine Agents, Histamine Antagonists, Histamine H1 Antagonists, Neurotransmitter Agents |
| Molecular Weight (dalton) | : | 265.36 |
| LogP | : | 2.6949 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 3 |
| Hydrogen Bond Donor Count | : | 1 |
| Total Polar Surface Area | : | 27.63 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category
| Toxicity | Source |
|---|---|
| Brain Injuries | MetaADEDB |
| Status Epilepticus | MetaADEDB |